Efficacy and Safety of Oral Nalbuphine Extended Release in Prurigo Nodularis: Results of a Phase 2, Randomized, Controlled Trial With an Open Open-Label Extension Phase. J of Skin 2021, 5 (1), s29. https://doi.org/10.25251/skin.5.supp.29.